acitretin has been researched along with Dermatoses in 50 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 6 (12.00) | 18.7374 |
1990's | 12 (24.00) | 18.2507 |
2000's | 10 (20.00) | 29.6817 |
2010's | 18 (36.00) | 24.3611 |
2020's | 4 (8.00) | 2.80 |
Authors | Studies |
---|---|
Borges-Costa, J; Filipe, P; Garrido, PM; Queirós, C; Soares-Almeida, L | 1 |
Enos, T; Rainwater, Y; Vandergriff, T; Vasquez, R; Wang, R | 1 |
Andersson, NW; Simonsen, AB; Thomsen, SF; Zachariae, C | 1 |
Cheong, SL; Coelho, R; Silva, G; Yau, SL | 1 |
Kaffenberger, BH; Tian, F; Vaynshtok, PM | 1 |
Baykal, C; Sun, GP; Yazganoğlu, KD | 1 |
Banney, L; Perry-Keene, J; Quinn, A; Weedon, D | 1 |
Alegre-de Miquel, V; García-Legaz-Martínez, M; Magdaleno-Tapial, J; Martínez-Domenech, Á; Sánchez-Carazo, JL; Valenzuela-Oñate, C | 1 |
Nofal, A; Nofal, E | 1 |
Azevedo, F; Bettencourt, H; Ferreira, O; Lisboa, C; Pedrosa, AF | 1 |
Butler, DF; Eduardo, C; Sutton, L | 1 |
Kervarrec, T; Machet, L; Machet, MC; Nadal, M; Petrella, T | 1 |
Gunia-Krzyżak, A; Marona, H; Słoczyńska, K; Waszkielewicz, AM; Żelaszczyk, D | 1 |
Kim, J; Kumarasinghe, SP; Papadimitriou, J; Yu, L | 1 |
Duffy, KL; Green, L; Harris, R; Powell, D | 1 |
Ehsani, AH; Toosi, S | 1 |
Gånemo, A; Jagell, S; Vahlquist, A | 1 |
Chroni, E; Monastirli, A; Tsambaos, D | 1 |
Campalani, E; Goodfield, MJ; Ormerod, AD | 1 |
Kraft, JN; Lynde, CB; Lynde, CW | 1 |
Dunn, LK; Feldman, SR; Gaar, LR; O'Neill, JL; Yentzer, BA | 1 |
Batard, ML; Cribier, B; Guillaume, JC; Kleinclauss, I; Merklen-Djafri, C | 1 |
Chappell, JA; Chu, MB; Hurley, MY; Martin, K | 1 |
Behzad, M; Michl, C; Pfützner, W | 1 |
Allen, GE; Dolan, OM; Irvine, AD; Irvine, D; McCarron, P; McMullen, EA | 1 |
Aydin, NE; Karaca, S; Ozcan, A; Senol, M | 1 |
Kathryn, M; Lebwohl, M | 1 |
Dohil, MA; Lam, J; Polifka, JE | 1 |
Bauer, R; Orfanos, CE | 1 |
Rollman, O; Vahlquist, A | 1 |
Bailey, RR; Davis, A; Macdonald, K; Yuan, ZF | 1 |
Cornel, MC; de Jong-Van Den Berg, LT; Stricker, BH; Sturkenboom, MC; van Voorst-Vader, PC; Wesseling, H | 1 |
Castanet, J; Lacour, JP; Ortonne, JP | 1 |
Geiger, JM; Saurat, JH | 1 |
Bleiker, TO; Bourke, JF; Graham-Brown, RA; Hutchinson, PE | 1 |
Fritsch, P; Reider, N; Sepp, N | 1 |
Katz, HI; Leach, EE; Waalen, J | 1 |
Brockhoff, PB; Grønhøj Larsen, F; Hjorter, A; Jakobsen, P; Nielsen-Kudsk, F; Steinkjer, B | 1 |
Aragüés, M; Daudén, E; Fraga, J; García-Díez, A; Hernández-Núñez, A; Moreno de Vega, MJ | 1 |
Blokx, WA; de Jong, EM; Link, MM; Ruiter, DJ; Smit, JV; van de Kerkhof, PC | 1 |
Gilardi, S; Hohl, D; Jung, T; Pelloni, F; Sigg, C | 1 |
Bitterling, T; Gollnick, H; Orfanos, CE; Rinck, G | 1 |
Halioua, B; Saurat, JH | 1 |
De Bersaques, JP; De Leenheer, AP; Kint, A; Lambert, WE | 1 |
van de Kerkhof, PC; van Ditzhuijsen, TJ; van Dooren-Greebe, RJ; van Haelst, UJ; Yap, SH | 1 |
Mérot, Y; Salomon, D; Saurat, JH; Siegenthaler, G | 1 |
Orfanos, CE | 1 |
Brindley, CJ; Geiger, JM | 1 |
Gollnick, H; Orfanos, CE; Stadler, R; Tsambaos, D | 1 |
12 review(s) available for acitretin and Dermatoses
Article | Year |
---|---|
Neuromuscular adverse effects associated with systemic retinoid dermatotherapy: monitoring and treatment algorithm for clinicians.
Topics: Acitretin; Administration, Oral; Biomarkers; Creatine Kinase; Dermatologic Agents; Drug Monitoring; Exercise; Humans; Hypervitaminosis A; Isotretinoin; Neuromuscular Diseases; Practice Guidelines as Topic; Skin Diseases | 2010 |
British Association of Dermatologists guidelines on the efficacy and use of acitretin in dermatology.
Topics: Acitretin; Drug Interactions; Drug Monitoring; Evidence-Based Medicine; Humans; Ichthyosis; Keratolytic Agents; Psoriasis; Skin Diseases | 2010 |
Acitretin in dermatology: a review.
Topics: Acitretin; Humans; Keratolytic Agents; Off-Label Use; Psoriasis; Skin Diseases; Skin Neoplasms | 2011 |
New roles for systemic retinoids.
Topics: Acitretin; Administration, Oral; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Graft Survival; Humans; Keratolytic Agents; Male; Organ Transplantation; Prognosis; Psoriasis; Retinoids; Risk Assessment; Skin Diseases; Treatment Outcome | 2006 |
Safety of dermatologic drugs used in pregnant patients with psoriasis and other inflammatory skin diseases.
Topics: Acitretin; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Female; Humans; Immunologic Factors; Keratolytic Agents; Pregnancy; Pregnancy Complications; Product Surveillance, Postmarketing; Psoriasis; Skin Diseases; Teratogens | 2008 |
Evidence for anti-inflammatory activities of oral synthetic retinoids: experimental findings and clinical experience.
Topics: Acitretin; Administration, Oral; Animals; Anti-Inflammatory Agents; Etretinate; Granulocytes; Humans; Isotretinoin; Leukocyte Count; Lymphocytes; Macrophages; Mice; Psoriasis; Skin Diseases; Skin Temperature; Tretinoin | 1983 |
Acitretin and etretinate. How and when they should be used.
Topics: Acitretin; Algorithms; Clinical Protocols; Drug Interactions; Drug Therapy, Combination; Etretinate; Humans; Mucous Membrane; PUVA Therapy; Skin; Skin Diseases | 1993 |
Acitretin in psoriasis: an overview of adverse effects.
Topics: Abnormalities, Drug-Induced; Acitretin; Drug Interactions; Etretinate; Eye Diseases; Female; Humans; Hyperlipidemias; Hyperostosis; Keratolytic Agents; Liver; Male; Mucous Membrane; Pancreatitis; Pseudotumor Cerebri; Skin Diseases | 1999 |
Widespread biphasic amyloidosis: response to acitretin.
Topics: Acitretin; Aged; Amyloidosis; Humans; Keratolytic Agents; Male; Skin Diseases | 2001 |
Risk: benefit ratio in the treatment of psoriasis with systemic retinoids.
Topics: Abnormalities, Drug-Induced; Acitretin; Adult; Aged; Bone Diseases; Chemical and Drug Induced Liver Injury; Etretinate; Eye Diseases; Female; Humans; Lipids; Male; Middle Aged; Psoriasis; Risk Factors; Skin Diseases; Tretinoin | 1990 |
[Retinoids: the new status. Maintenance therapy, disorders of resorption in "non-responders", interactions and interferences with drugs, treatment of children and bone toxicity, acitetin and 13-cis-acitretin].
Topics: Acitretin; Adult; Bone and Bones; Child; Humans; Intestinal Absorption; Long-Term Care; Retinoids; Skin Diseases; Tretinoin | 1989 |
Current developments of oral retinoid therapy with three generations of drugs. Non-aromatic, monoaromatic and polyaromatic retinoids (arotinoids).
Topics: Acitretin; Administration, Oral; Benzoates; Eczema; Etretinate; Humans; Isotretinoin; Psoriasis; Retinoids; Skin Diseases; Skin Diseases, Vesiculobullous; Tretinoin | 1985 |
1 trial(s) available for acitretin and Dermatoses
Article | Year |
---|---|
Inability to detect plasma etretinate and acitretin is a poor predictor of the absence of these teratogens in tissue after stopping acitretin treatment.
Topics: Acitretin; Adipose Tissue; Adolescent; Adult; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Etretinate; Female; Follow-Up Studies; Humans; Middle Aged; Netherlands; Product Surveillance, Postmarketing; Sensitivity and Specificity; Single-Blind Method; Skin Diseases; Teratogens; Tissue Distribution | 1994 |
37 other study(ies) available for acitretin and Dermatoses
Article | Year |
---|---|
Acquired perforating dermatosis: clinicopathologic study of a 10-year period at a tertiary teaching hospital.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Chronic Disease; Diabetes Mellitus; Drug Therapy, Combination; Female; Glucocorticoids; Histamine Antagonists; Hospitals, Teaching; Humans; Lower Extremity; Male; Mental Disorders; Middle Aged; Neoplasms; Phototherapy; Portugal; Renal Insufficiency, Chronic; Retrospective Studies; Severity of Illness Index; Skin; Skin Diseases; Tertiary Care Centers; Treatment Outcome; Virus Diseases | 2020 |
Treatment of extensive elastosis perforans serpiginosa with acitretin in a man with Down syndrome.
Topics: Acitretin; Down Syndrome; Elastic Tissue; Humans; Male; Skin Diseases | 2021 |
Safety of the combined use of methotrexate and acitretin in a dermatology hospital setting.
Topics: Acitretin; Adult; Aged; Chemical and Drug Induced Liver Injury; Dermatologic Agents; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Skin Diseases | 2021 |
Unusual cutaneous manifestations and congenital hearing loss in a patient with GJB2 (F142L) mutation.
Topics: Acitretin; Adalimumab; Combined Modality Therapy; Connexin 26; Deafness; Dermatologic Agents; Humans; Male; Mutation; Skin Diseases; Skin Transplantation; Young Adult | 2021 |
Acitretin amelioration of Acrokeratosis Paraneoplastica (Bazex Syndrome) in cases of incurable squamous cell carcinoma of the hypopharynx.
Topics: Acitretin; Aged; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Female; Head and Neck Neoplasms; Humans; Hypopharyngeal Neoplasms; Hypotrichosis; Keratolytic Agents; Male; Middle Aged; Paraneoplastic Syndromes; Skin Diseases; Skin Neoplasms; Squamous Cell Carcinoma of Head and Neck | 2016 |
Superficial cutaneous hemorrhagic lesions in three mycosis fungoides patients using acitretin.
Topics: Acitretin; Aged; Female; Hemorrhage; Humans; Keratolytic Agents; Male; Middle Aged; Mycosis Fungoides; Skin Diseases; Skin Neoplasms | 2017 |
Eruptive keratoacanthomas in tattoos.
Topics: Acitretin; Adult; Female; Humans; Keratoacanthoma; Keratolytic Agents; Male; Middle Aged; Skin Diseases; Tattooing | 2017 |
A pruriginous eruption on the back, worsening in the summer.
Topics: Acitretin; Administration, Oral; Darier Disease; Exanthema; Humans; Keratolytic Agents; Male; Middle Aged; Mutation; Pruritus; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Seasons; Skin; Skin Diseases; Treatment Outcome | 2019 |
Multiple eruptive keratoacanthomas: a confusing term?
Topics: Acitretin; Humans; Keratoacanthoma; Male; Myelodysplastic Syndromes; Skin Diseases | 2013 |
Acitretin: no pregnancy during treatment and, as a precaution, for 3 years after discontinuation.
Topics: Acitretin; Female; Humans; Keratolytic Agents; Pregnancy; Skin Diseases; Teratogens; Time Factors | 2013 |
Primary Langerhans cell histiocytosis of the vulva: acitretin as a glucocorticoid-sparing agent.
Topics: Acitretin; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Histiocytosis, Langerhans-Cell; Humans; Keratolytic Agents; Prednisolone; Scalp Dermatoses; Skin Diseases; Vulvar Diseases | 2014 |
Diffuse lichenplanopilaris and multiple squamous neoplasms.
Topics: Acitretin; Aged; Carcinoma, Squamous Cell; Dermatitis; Female; Humans; Hypertrophy; Keratoacanthoma; Keratolytic Agents; Lichen Planus; Skin Diseases; Skin Neoplasms | 2015 |
Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
Topics: Acitretin; Administration, Cutaneous; Aged; Anti-Inflammatory Agents; Breast Diseases; Clobetasol; Dermatologic Agents; Female; Histiocytosis, Sinus; Humans; Immunosuppressive Agents; Keratolytic Agents; Methotrexate; Retreatment; Skin Diseases; Thalidomide; Treatment Failure | 2015 |
Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals.
Topics: Acitretin; Adapalene; Administration, Topical; Bexarotene; Cosmeceuticals; Cytochrome P-450 Enzyme System; Humans; Hydroxylation; Inactivation, Metabolic; Retinoids; Skin; Skin Diseases; Software; Structure-Activity Relationship; Tetrahydronaphthalenes; Vitamin A | 2015 |
Cyclical Inguinal Keratoderma: A New Clinical Entity or a Variant of Pityriasis Rubra Pilaris?
Topics: Acitretin; Biopsy, Needle; Diagnosis, Differential; Humans; Immunohistochemistry; Keratosis; Male; Middle Aged; Pityriasis Rubra Pilaris; Pruritus; Recurrence; Scrotum; Skin Diseases; Thigh; Treatment Outcome | 2016 |
Treatment of nephrogenic systemic fibrosis with Re-PUVA.
Topics: Acitretin; Fibrosis; Humans; Keratolytic Agents; Kidney Failure, Chronic; Male; Middle Aged; PUVA Therapy; Skin Diseases | 2008 |
Treatment of lipoid proteinosis with acitretin: a case report.
Topics: Acitretin; Child, Preschool; Female; Humans; Keratolytic Agents; Lipoid Proteinosis of Urbach and Wiethe; Skin Diseases; Treatment Outcome | 2009 |
Sjögren-larsson syndrome: a study of clinical symptoms and dermatological treatment in 34 Swedish patients.
Topics: Acitretin; Adult; Aged; Female; Humans; Ichthyosis; Interviews as Topic; Keratolytic Agents; Learning Disabilities; Male; Middle Aged; Sjogren-Larsson Syndrome; Skin Diseases; Speech Disorders; Sweden | 2009 |
Acitretin revisited.
Topics: Acitretin; Humans; Keratolytic Agents; Randomized Controlled Trials as Topic; Skin Diseases | 2011 |
[Folliculosebaceous cystic hamartoma: anatomo-clinical study].
Topics: Acitretin; Adipocytes; Adolescent; Adult; Aged; Aged, 80 and over; Combined Modality Therapy; Diagnosis, Differential; Epidermal Cyst; Facial Dermatoses; Female; Follicular Cyst; Hair Follicle; Hamartoma; Humans; Isotretinoin; Lasers, Gas; Male; Middle Aged; Neoplasms, Basal Cell; Radiodermatitis; Retrospective Studies; Skin Diseases; Skin Neoplasms; Stromal Cells; Young Adult | 2012 |
Acitretin-induced poliosis with concurrent alopecia.
Topics: Acitretin; Alopecia; Humans; Male; Middle Aged; Pigmentation Disorders; Skin Diseases | 2012 |
Multiple eruptive keratoacanthomas associated with myelodysplastic syndrome.
Topics: Acitretin; Aged; Humans; Keratoacanthoma; Keratolytic Agents; Male; Myelodysplastic Syndromes; Skin Diseases; Treatment Outcome | 2012 |
Association between long-term acitretin therapy and osteoporosis: no evidence of increased risk.
Topics: Absorptiometry, Photon; Acitretin; Adult; Aged; Bone Density; Chronic Disease; Drug Administration Schedule; Female; Femur Neck; Humans; Keratolytic Agents; Lumbar Vertebrae; Male; Middle Aged; Osteoporosis; Risk Assessment; Skin Diseases | 2003 |
Amyloidosis cutis dyschromica: a case treated with acitretin.
Topics: Acitretin; Adult; Amyloidosis; Biopsy, Needle; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; Humans; Hypopigmentation; Immunohistochemistry; Male; Severity of Illness Index; Skin Diseases; Treatment Outcome | 2005 |
Retinoid concentrations in skin, serum and adipose tissue of patients treated with etretinate.
Topics: Acitretin; Adipose Tissue; Adolescent; Adult; Aged; Biological Availability; Child; Etretinate; Female; Humans; Male; Middle Aged; Skin; Skin Diseases; Tretinoin | 1983 |
Use of acitretin for the skin complications in renal transplant recipients.
Topics: Acitretin; Adult; Aged; Female; Humans; Keratosis; Kidney Transplantation; Male; Middle Aged; Skin Diseases; Skin Neoplasms; Warts | 1995 |
Milia during treatment of mycosis fungoides: follicular mycosis fungoides?
Topics: Acitretin; Humans; Mycosis Fungoides; Skin Diseases; Skin Neoplasms | 1994 |
Etretinate may work where acitretin fails.
Topics: Acitretin; Adolescent; Adult; Aged; Aged, 80 and over; Darier Disease; Etretinate; Female; Hand Dermatoses; Humans; Keratoderma, Palmoplantar; Keratolytic Agents; Male; Psoriasis; Skin Diseases; Treatment Failure | 1997 |
Remission of lichen amyloidosus after treatment with acitretin.
Topics: Acitretin; Aged; Amyloidosis; Coloring Agents; Complement C3; Congo Red; Female; Fluorescent Antibody Technique, Direct; Humans; Immunoglobulin M; Keratolytic Agents; Skin Diseases | 1997 |
Acitretin is converted to etretinate only during concomitant alcohol intake.
Topics: Acitretin; Adult; Aged; Aged, 80 and over; Alcohol Drinking; Central Nervous System Depressants; Chromatography, High Pressure Liquid; Ethanol; Etretinate; Female; Humans; Keratolytic Agents; Logistic Models; Male; Middle Aged; Risk Factors; Skin Diseases | 2000 |
Retinoids strongly and selectively correlate with keratin 13 and not keratin 19 expression in cutaneous warts of renal transplant recipients.
Topics: Acitretin; Adult; Aged; Confidence Intervals; Culture Techniques; Female; Humans; Immunohistochemistry; Keratins; Kidney Transplantation; Male; Middle Aged; Probability; Reference Values; Retrospective Studies; Sensitivity and Specificity; Skin Diseases; Warts | 2002 |
A prospective study of skeletal changes during short-term acitretin therapy.
Topics: Acitretin; Adolescent; Bone and Bones; Bone Diseases; Female; Humans; Male; Middle Aged; Prospective Studies; Skin Diseases; Spinal Diseases; Tretinoin | 1992 |
[Pharmacokinetics of etretinate, acitretin and 13-cis-acitretin: new results and advantages of blood level oriented clinical use].
Topics: Acitretin; Administration, Oral; Adult; Aged; Chromatography, High Pressure Liquid; Etretinate; Female; Humans; Long-Term Care; Male; Middle Aged; Psoriasis; Skin Diseases; Tretinoin | 1990 |
Persistent etretinate levels in plasma after changing the therapy to acitretin.
Topics: Acitretin; Aged; Drug Interactions; Etretinate; Female; Humans; Male; Middle Aged; Skin Diseases; Tretinoin | 1990 |
Severe hepatotoxic reaction with progression to cirrhosis after use of a novel retinoid (acitretin).
Topics: Acitretin; Female; Humans; Liver; Liver Cirrhosis; Microscopy, Electron; Middle Aged; Skin Diseases; Tretinoin | 1990 |
Skin cellular retinoid-binding proteins and retinoid-responsive dermatoses.
Topics: Acitretin; Adsorption; Carrier Proteins; Charcoal; Chromatography, Gel; Dextrans; Female; Humans; Male; Psoriasis; Receptors, Retinoic Acid; Retinol-Binding Proteins; Retinol-Binding Proteins, Cellular; Skin; Skin Diseases; Tretinoin | 1986 |
Cis-trans interconversion of acitretin in man.
Topics: Acitretin; Adult; Aged; Animals; Biotransformation; Dermatitis; Female; Half-Life; Humans; Male; Middle Aged; Psoriasis; Rats; Skin Diseases; Stereoisomerism; Tretinoin | 1988 |